Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$63.83 - $80.0 $220,596 - $276,480
-3,456 Closed
0 $0
Q1 2022

Apr 25, 2022

SELL
$76.85 - $89.45 $166,226 - $193,480
-2,163 Reduced 38.49%
3,456 $268,000
Q3 2021

Oct 20, 2021

SELL
$73.77 - $83.61 $43,524 - $49,329
-590 Reduced 9.5%
5,619 $452,000
Q2 2021

Jul 27, 2021

SELL
$80.5 - $88.01 $10,062 - $11,001
-125 Reduced 1.97%
6,209 $500,000
Q4 2020

Jan 25, 2021

SELL
$75.39 - $82.36 $72,902 - $79,642
-967 Reduced 13.24%
6,334 $508,000
Q3 2020

Oct 21, 2020

SELL
$78.33 - $90.73 $5,091 - $5,897
-65 Reduced 0.88%
7,301 $587,000
Q2 2020

Jul 24, 2020

SELL
$78.66 - $94.14 $2,517 - $3,012
-32 Reduced 0.43%
7,366 $634,000
Q1 2020

Apr 24, 2020

SELL
$71.57 - $93.3 $42,941 - $55,980
-600 Reduced 7.5%
7,398 $601,000
Q3 2019

Oct 23, 2019

BUY
$81.4 - $89.78 $2,604 - $2,872
32 Added 0.4%
7,998 $700,000
Q2 2019

Jul 26, 2019

SELL
$73.44 - $82.41 $42,962 - $48,209
-585 Reduced 6.84%
7,966 $652,000
Q1 2019

Apr 12, 2019

SELL
$64.48 - $81.31 $137,535 - $173,434
-2,133 Reduced 19.96%
8,551 $696,000
Q4 2018

Jan 29, 2019

SELL
$61.45 - $77.8 $4,301 - $5,446
-70 Reduced 0.65%
10,684 $703,000
Q3 2018

Oct 24, 2018

BUY
$70.71 - $77.75 $707 - $777
10 Added 0.09%
10,754 $829,000
Q2 2018

Jul 11, 2018

SELL
$63.43 - $75.41 $158,892 - $188,902
-2,505 Reduced 18.91%
10,744 $794,000
Q1 2018

Apr 16, 2018

SELL
$62.56 - $72.26 $23,084 - $26,663
-369 Reduced 2.71%
13,249 $862,000
Q4 2017

Jan 30, 2018

BUY
$61.45 - $66.05 $7,742 - $8,322
126 Added 0.93%
13,618 $881,000
Q3 2017

Oct 10, 2017

BUY
$59.5 - $64.61 $802,774 - $871,718
13,492
13,492 $847,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Ledyard National Bank Portfolio

Follow Ledyard National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.